Stocks
Cassava Sciences Inc Financial Statements (SAVA) |
||||||||||
| Cassava Sciences Incsmart-lab.ru | % | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 07.11.2023 | 28.02.2024 | 10.05.2024 | 08.08.2024 | 07.11.2024 | 07.11.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 0.000 | 2.35 | 0.000 | 0.000 | 0.000 | 2.35 | |||
| Operating Income, bln rub | -27.9 | -22.8 | -19.9 | -67.2 | -30.6 | -140.5 | ||||
| EBITDA, bln rub | ? | -27.5 | -22.4 | -19.6 | -61.1 | -30.4 | -133.5 | |||
| Net profit, bln rub | ? | -25.7 | -20.9 | 25.0 | 6.16 | -27.9 | -17.7 | |||
| OCF, bln rub | ? | -26.5 | -22.3 | -19.1 | -18.2 | -18.3 | -78.0 | |||
| CAPEX, bln rub | ? | 0.022 | 0.041 | 0.000 | 0.029 | 0.017 | 0.087 | |||
| FCF, bln rub | ? | -26.6 | -22.4 | -19.1 | -18.3 | -18.3 | -78.1 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 27.9 | 22.4 | 19.6 | 66.9 | 30.6 | 139.6 | ||||
| Cost of production, bln rub | 0.392 | 0.356 | 0.311 | 0.300 | 0.000 | 0.967 | ||||
| R&D, bln rub | 23.6 | 18.7 | 16.2 | 15.2 | 17.7 | 67.8 | ||||
| Interest expenses, bln rub | 0.000 | 2.63 | 0.000 | 0.000 | 0.000 | 2.63 | ||||
| Assets, bln rub | 172.5 | 151.7 | 155.7 | 243.6 | 223.8 | 223.8 | ||||
| Net Assets, bln rub | ? | 155.1 | 137.5 | 78.6 | 189.0 | 166.6 | 166.6 | |||
| Debt, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Cash, bln rub | 142.4 | 121.1 | 124.2 | 207.3 | 149.0 | 149.0 | ||||
| Net debt, bln rub | -142.4 | -121.1 | -124.2 | -207.3 | -149.0 | -149.0 | ||||
| Ordinary share price, rub | 16.6 | 22.5 | 20.3 | 12.4 | 29.4 | 25.8 | ||||
| Number of ordinary shares, mln | 42.0 | 42.2 | 43.0 | 46.2 | 48.0 | 48.0 | ||||
| Market cap, bln rub | 699 | 950 | 872 | 571 | 1 412 | 1 235 | ||||
| EV, bln rub | ? | 557 | 829 | 748 | 363 | 1 263 | 1 086 | |||
| Book value, bln rub | 155 | 137 | 78 | 189 | 167 | 167 | ||||
| EPS, rub | ? | -0.61 | -0.50 | 0.58 | 0.13 | -0.58 | -0.37 | |||
| FCF/share, rub | -0.63 | -0.53 | -0.44 | -0.40 | -0.38 | -1.63 | ||||
| BV/share, rub | 3.69 | 3.25 | 1.83 | 4.09 | 3.47 | 3.47 | ||||
| EBITDA margin, % | ? | -955.4% | -5 686% | |||||||
| Net margin, % | ? | -890.9% | -752.3% | |||||||
| FCF yield, % | ? | -11.6% | -8.68% | -10.1% | -15.1% | -5.53% | -6.32% | |||
| ROE, % | ? | -58.7% | -68.8% | -60.9% | -8.13% | -10.6% | -10.6% | |||
| ROA, % | ? | -52.7% | -62.4% | -30.8% | -6.31% | -7.89% | -7.89% | |||
| P/E | ? | -7.68 | -10.0 | -18.2 | -37.1 | -79.9 | -69.9 | |||
| P/FCF | -8.62 | -11.5 | -9.92 | -6.61 | -18.1 | -15.8 | ||||
| P/S | ? | 0.00 | 404.5 | 371.6 | 243.0 | 601.3 | 526.1 | |||
| P/BV | ? | 4.51 | 6.92 | 11.1 | 3.02 | 8.48 | 7.42 | |||
| EV/EBITDA | ? | -5.37 | -7.87 | -7.61 | -2.78 | -9.46 | -8.14 | |||
| Debt/EBITDA | 1.37 | 1.15 | 1.26 | 1.59 | 1.12 | 1.12 | ||||
| R&D/CAPEX, % | 107 286% | 45 685% | 52 407% | 103 976% | 77 975% | |||||
| CAPEX/Revenue, % | 1.75% | 3.71% | ||||||||
| Cassava Sciences Inc shareholders | ||||||||||
